|
ALPHA GUIDE A |
B |
C |
D |
E |
F |
G |
H |
I | J | K |
L |
M |
N |
O |
P |
Q |
R |
S |
T | U |
V |
W |
X | Y |
Z
Common Name: Rutin
Synonyms: Rutoside, quercetin-3-rutinoside, sophorin
Overview:
Rutin is a bioflavonoid and is found in citrus fruits, noni, apple
peel and black tea. The richest source of rutin however is not a fruit
or vegetable but a grain, buckwheat. Rutin is
light yellow and is a combination of quercetin and a disaccharide (a
type of sugar) rutinose. Rutin is an antioxidant and most of its health
enhancing properties can be linked to its ability to scavenge the free
radicals. Rutin is essential to the body’s ability to process vitamin
C, maintain the strength of the walls of capillaries as well as
strengthen the collagen matrix that cements the body together. Rutin
also combines with excess iron store in the liver and brain thereby
reducing the production of oxygen radicals and cell damage.
A lack of sufficient of rutin in the diet has been associated with
pain, weakness and a weakening of the capillaries in the arms and legs.
It is often used to treat chronic venous insufficiency (CIV). It does
this by improving the flexibility of the venous and improving their
tone. It has been shown to reduce the leakage from the small
capillaries in the retina, therefore helping to prevent bleeding and
blindness. As with other bioflavonoids, rutin works better when given
with vitamin C.
Benefits
Studies have shown:
- In early studies that daily doses of rutin ranging from
200-600mg were beneficial in treating capillary fragility (a condition
that leads to easy bruising). Although no studies have been conducted
as yet, it has been suggested that rutin supplements may reduce the
incidence of cerebral hemorrhage. In a placebo-controlled study a
significant reduction of mid-cycle menstrual bleeding was seen in women
who took a rutin supplement.
- In several placebo controlled
studies, it was shown that rutin supplementation helps significantly in
reducing the venous edema (filling with fluid) that is an early symptom
of chronic venous disease of the legs.
- That in animal
studies, rutin’s ability to increase glutathione levels as well as its
anti-inflammatory properties where responsible for preventing colitis
flare ups and in reducing the tissue damage that is often associated
with a flare up. Other studies rutin has shown the ability to protect
cells in ethanol induced gastric lesions.
- That rutin’s
iron-chelating abilities keep the iron from binding to hydrogen
peroxide and creating a highly reactive free radical. Because of this
ability, rutin offers significant protection to liver and brain cells
caused by this potent free radical.
- That taken in
conjunction with vitamin C inhibits the breakdown of this vital
nutrient thereby increasing vitamin C’s ability to do its job.
Dietary Sources
Good sources of are:
|
Buckwheat |
|
Noni |
|
Apple Peels |
|
Black tea |
 Citrus fruits |
Recommended Dosage:
For venous insufficiency and varicose veins take 500mg taken twice a day
As a nutritional supplement take 500mg once or twice a day.
Tablets come in doses of 50mg, 250mg and 500mg
Contra-indications
Rutin and meats containing nitrates and nitrites (luncheon meats,
ham and bacon) should not be eaten together. There is a possibility of
forming a compound that has the potential to cause gene mutations and
even cancer.
Women who are pregnant or breastfeeding should not take rutin
supplements. There have been no studies of rutin in children. It is
recommended that rutin supplements should not be used in children.
There have been a few reports of gastrointestinal upset as well as
headaches and a mild tingling in the arms and legs when taking rutin
supplements.
Drug interactions
- Do not take rutin with the quinilone antibiotics. It may
inhibit these antibiotics’ ability to do their job of destroying
bacteria causing an infection.
- Rutin and other
bioflavonoids tend to reduce blood platelet stickiness in a beneficial
way and therefore may reduce the dosage required for blood thinners.
Individuals taking blood thinners should consult with their physician
prior to starting rutin supplementation.
Web References
- http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/rut_0230.shtml
- http://en.wikipedia.org/wiki/Rutin
- http://healthlibrary.epnet.com/GetContent.aspx?token=e0498803-7f62-4563-8d47-5fe33da65dd4&chunkiid=21574
- http://lpi.oregonstate.edu/infocenter/phytochemicals/flavonoids/index.html
Printed Reference Material
- Cesarone MR, Incandela L, DeSanctis MT,
Belcaro G, Dugall M, Acerbi G. 2002. Variations in plasma free radicals
in patients with venous hypertension with HR (Paroven, Venoruton;
0-(beta-hydroxyethyl)-rutosides): a clinical, prospective,
placebo-controlled, randomized trial. J Cardiovasc Pharmacol Ther 2002
Jan; 7 Suppl 1: S25-8.
- Cesarone MR, Incandela L,
DeSanctis MT, Belcaro G, Griffin M, Ippolito E, Acerbi G. 2002.
Treatment of edema and increased capillary filtration in venous
hypertension with HR (Paroven, Venoruton;
0-(beta-hydroxyethyl)-rutosides): a clinical, prospective,
placebo-controlled, randomized, dose-ranging trial. J Cardiovasc
Pharmacol Ther 2002 Jan; 7 Suppl 1: S21-4.
- Clement DL. Management of venous edema: insights from an international task force. Angiology. 2000; 51:13-17.
- Cruz T, Galvez J, Ocete MA, et al. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci. 1998; 62:687-695.
- Deschner
EE, Ruperto JF. Wong GY, Newmark HL. The effect of dietary quercetin
and rutin on AOM-induced acute colonic epithelial abnormalities in mice
fed a high-fat diet. Nutr Cancer. 1993; 20:199-204.
- Drewa
G, Schachtschabel DO, Palgan K, et al. The influence of rutin on the
weight, metastasis and melanin content of B16 melanotic melanoma in
C57BL/6 mice. Neoplasma. 1998; 45:266-271.
- Galvez J, Cruz T, Crespo E, et al. Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med. 1997; 63:409-414.
- Incandela
L, Cesarone MR, DeSanctis MT, Belcaro G, Dugall M, Acerbi G. 2002.
Treatment of diabetic microangiopathy and edema with HR (Paroven,
Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective,
placebo-controlled, randomized study. J Cardiovasc Pharmacol Ther 2002
Jan; 7 Suppl 1: S11-5.
- Kostyuk VA, Potapovich AI, Speransky
SD, Maslova GT. Protective effect of natural flavonoids on rat
peritoneal macrophages injury caused by asbestos fiber. Free Rad Biol Med. 1996; 21:487-493.
- Kostyuk VA, Potapovich AI. Antiradical and chelating effects in flavonoid protection against silica-induced cell injury. Arch Biochem Biophys. 1998; 355:43-48.
- Olthof
MR, Hollman PC, Vree TB, Katan MB. Bioavailabilities of
quercetin-3-glucoside and quercetin-4'-glucoside do not differ in
humans. J Nutr. 2000; 130:1200-1203.
- Park JB,
Levine M. Intracellular accumulation of ascorbic acid is inhibited by
flavonoids via blocking of dehydroascorbic acid and ascorbic acid
uptakes in HL-60, U937 and Jurkat cells. J Nutr. 2000; 130:1297-1302.
- Perez
Guerrero C, Martin MG, Marhuenda E. Prevention by rutin of gastric
lesions induced by ethanol in rats: role of endogenous prostaglandins. Gen Pharmacol. 1994; 25:575-580.
- Petruzzellis
V, Troccoli T, Candiani C, Guarisco R, Lospalluti M, Belcaro G, Dugall
M. 2002. Oxerutins (Venoruton): efficacy in chronic venous
insufficiency--a double-blind, randomized, controlled study. Angiology
2002 May-Jun; 53(3): 257-63.
- Rueff J, Gaspar J, Laires A.
Structural requirements for mutagenicity of flavonoids upon
nitrosation. A structure-activity study. Mutagenesis. 1995; 10:325-328.
- Schmitt
A, Savayre R, Delchambre J, Negre-Salvayre A. Prevention by
alpha-tocopherol and rutin of glutathione and ATP depletion induced by
oxidized LDL in cultured endothelial cells. Br J Pharmacol. 1995; 116:1985-1990.
- Titapant
V, Indrasukhsri B, Lekprasert V, Boonnuch W. 2001.
Trihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy:
a double-blind placebo-controlled trial. J Med Assoc Thai 2001 Oct;
84(10): 1395-400.
- Webster RP, Gawde MD, Bhattacharya RK,
Protective effect of rutin, a flavonol glycoside, on the
carcinogen-induced DNA damage and repair enzymes in rats. Cancer Lett. 1996; 109:185-191.
|
|